Herman Devijver
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation.
Journal: EBioMedicine
Published: August 29, 2018
GSK3β Controls mTOR and Prosurvival Signaling in Neurons.
Journal: Molecular neurobiology
Published: June 08, 2017
Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.
Journal: Journal of Alzheimer's disease : JAD
Published: December 31, 2016
GSK-3β and MMP-9 Cooperate in the Control of Dendritic Spine Morphology.
Journal: Molecular neurobiology
Published: October 26, 2015
Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
Journal: The European journal of neuroscience
Published: February 06, 2014
Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
Journal: Neurobiology of disease
Published: January 23, 2014
Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
Journal: PloS one
Published: October 29, 2013
Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase.
Journal: Molecular brain
Published: April 02, 2013
Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare.
Journal: PloS one
Published: January 24, 2013
Glycogen synthase kinase-3beta affects size of dentate gyrus and species-typical behavioral tasks in transgenic and knockout mice.
Journal: Behavioural brain research
Published: September 05, 2012
Last Updated: 09/26/2026